• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Antibiotic susceptibility pattern of Mycobacterium marinum.海分枝杆菌的抗生素敏感性模式
Antimicrob Agents Chemother. 2000 Nov;44(11):3133-6. doi: 10.1128/AAC.44.11.3133-3136.2000.
2
Antimicrobial susceptibility of Mycobacterium marinum determined by E-test and agar dilution.采用E试验和琼脂稀释法测定海分枝杆菌的抗菌药敏性。
Scand J Infect Dis. 2001;33(8):585-8. doi: 10.1080/00365540110026773.
3
Evaluation of the SLOMYCO Sensititre(®) panel for testing the antimicrobial susceptibility of Mycobacterium marinum isolates.评估SLOMYCO Sensititre(®)平板用于检测海分枝杆菌分离株的抗菌药敏性。
Ann Clin Microbiol Antimicrob. 2016 May 6;15:30. doi: 10.1186/s12941-016-0145-1.
4
Application of the Etest to the antimicrobial susceptibility testing of Mycobacterium marinum clinical isolates.Etest在海分枝杆菌临床分离株抗菌药敏试验中的应用。
J Clin Microbiol. 1997 Aug;35(8):2083-6. doi: 10.1128/jcm.35.8.2083-2086.1997.
5
Evaluation of Etest for rapid susceptibility testing of Mycobacterium chelonae and M. fortuitum.用于龟分枝杆菌和偶然分枝杆菌快速药敏试验的Etest评估。
J Clin Microbiol. 1994 Aug;32(8):1846-9. doi: 10.1128/jcm.32.8.1846-1849.1994.
6
In vitro activity of 11 antimicrobial agents, including gatifloxacin and GAR936, tested against clinical isolates of Mycobacterium marinum.11种抗菌剂(包括加替沙星和GAR936)对海分枝杆菌临床分离株的体外活性。
Diagn Microbiol Infect Dis. 2002 Feb;42(2):145-7. doi: 10.1016/s0732-8893(01)00332-7.
7
Comparison of E-test with agar dilution methods in testing susceptibility of N. gonorrhoeae to azithromycin.E试验与琼脂稀释法检测淋病奈瑟菌对阿奇霉素敏感性的比较。
Sex Transm Dis. 1997 May;24(5):257-60. doi: 10.1097/00007435-199705000-00004.
8
[Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].[龟分枝杆菌和脓肿分枝杆菌的药敏分析及Etest药敏试验评估]
Zhonghua Jie He He Hu Xi Za Zhi. 2013 Aug;36(8):567-71.
9
Comparison of the Etest and the NCCLS-approved agar dilution method to detect metronidazole and clarithromycin resistant Helicobacter pylori.比较Etest法与美国国家临床实验室标准委员会(NCCLS)认可的琼脂稀释法检测耐甲硝唑和克拉霉素幽门螺杆菌的效果。
Int J Antimicrob Agents. 2001 Jan;17(1):39-44. doi: 10.1016/s0924-8579(00)00320-4.
10
Multisite reproducibility of Etest for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.用于脓肿分枝杆菌、龟分枝杆菌和偶发分枝杆菌药敏试验的Etest的多中心再现性。
J Clin Microbiol. 2000 Feb;38(2):656-61. doi: 10.1128/JCM.38.2.656-661.2000.

引用本文的文献

1
In vivo antimicrobial activity of engineered mesoporous silica nanoparticles targeting intracellular mycobacteria.靶向细胞内分枝杆菌的工程化介孔二氧化硅纳米颗粒的体内抗菌活性
Nat Commun. 2025 Aug 11;16(1):7388. doi: 10.1038/s41467-025-62623-y.
2
infection model: a powerful high-throughput screening platform for anti-infective compounds.感染模型:用于抗感染化合物的强大高通量筛选平台。
Front Microbiol. 2025 Jul 4;16:1612354. doi: 10.3389/fmicb.2025.1612354. eCollection 2025.
3
Fluoroquinolones for Dermatologists: A Practical Guide to Clinical Use and Risk Management.皮肤科医生使用氟喹诺酮类药物:临床应用与风险管理实用指南
Pharmaceuticals (Basel). 2025 May 26;18(6):800. doi: 10.3390/ph18060800.
4
One-step loop-mediated isothermal amplification system for detection.用于检测的一步法环介导等温扩增系统。
Microbiol Spectr. 2025 Jul;13(7):e0290624. doi: 10.1128/spectrum.02906-24. Epub 2025 Jun 11.
5
Exploring the Antimycobacterial Potential of Podocarpusflavone A from : In Vitro and In Vivo Insights.探索来自罗汉松黄酮A的抗分枝杆菌潜力:体外和体内研究见解
Pharmaceuticals (Basel). 2024 Nov 21;17(12):1560. doi: 10.3390/ph17121560.
6
Molecular mechanism of a triazole-containing inhibitor of DNA gyrase.一种含三唑的DNA促旋酶抑制剂的分子机制
iScience. 2024 Sep 16;27(10):110967. doi: 10.1016/j.isci.2024.110967. eCollection 2024 Oct 18.
7
Discovery of anti-infective compounds against after biotransformation of simple natural stilbenes by a fungal secretome.真菌分泌组对简单天然芪类化合物进行生物转化后发现抗感染化合物。
Front Microbiol. 2024 Sep 17;15:1439814. doi: 10.3389/fmicb.2024.1439814. eCollection 2024.
8
Mycobacterium ulcerans challenge strain selection for a Buruli ulcer controlled human infection model.溃疡分枝杆菌挑战株的选择用于控制人类感染的伯氏疏螺旋体溃疡模型。
PLoS Negl Trop Dis. 2024 May 3;18(5):e0011979. doi: 10.1371/journal.pntd.0011979. eCollection 2024 May.
9
Genomic and phenotypic characterization of closest-related non-tuberculous mycobacteria.亲缘相近非结核分枝杆菌的基因组和表型特征分析。
Microbiol Spectr. 2024 Jun 4;12(6):e0412623. doi: 10.1128/spectrum.04126-23. Epub 2024 May 3.
10
Antibiotic susceptibility and resistance genes profiles of in a rainbow trout (, Walbaum) farm.在虹鳟鱼(Oncorhynchus mykiss,Walbaum)养殖场中 的抗生素药敏性和耐药性基因谱。
PeerJ. 2024 Mar 28;12:e17194. doi: 10.7717/peerj.17194. eCollection 2024.

本文引用的文献

1
Anonymous mycobacteria in pulmonary disease.肺部疾病中的非结核分枝杆菌
Med Clin North Am. 1959 Jan;43(1):273-90. doi: 10.1016/s0025-7125(16)34193-1.
2
Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in mycobacteria.分枝杆菌中喹诺酮敏感性模式与DNA促旋酶A和B亚基序列之间的相关性
Antimicrob Agents Chemother. 1998 Aug;42(8):2084-8. doi: 10.1128/AAC.42.8.2084.
3
In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis.莫西沙星和克林沙星对结核分枝杆菌的体外及体内活性
Antimicrob Agents Chemother. 1998 Aug;42(8):2066-9. doi: 10.1128/AAC.42.8.2066.
4
Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association.非结核分枝杆菌所致疾病的诊断与治疗。本美国胸科学会官方声明于1997年3月经董事会批准。美国肺脏协会医学部。
Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 2):S1-25. doi: 10.1164/ajrccm.156.2.atsstatement.
5
Application of the Etest to the antimicrobial susceptibility testing of Mycobacterium marinum clinical isolates.Etest在海分枝杆菌临床分离株抗菌药敏试验中的应用。
J Clin Microbiol. 1997 Aug;35(8):2083-6. doi: 10.1128/jcm.35.8.2083-2086.1997.
6
Testing of Mycobacterium tuberculosis susceptibility to ethambutol, isoniazid, rifampin, and streptomycin by using Etest.采用Etest法检测结核分枝杆菌对乙胺丁醇、异烟肼、利福平及链霉素的敏感性。
J Clin Microbiol. 1996 Jul;34(7):1672-6. doi: 10.1128/JCM.34.7.1672-1676.1996.
7
Evaluation of the Etest for rapid susceptibility testing of Mycobacterium avium to clarithromycin.评价Etest法对鸟分枝杆菌进行克拉霉素快速药敏试验的效果。
J Antimicrob Chemother. 1996 May;37(5):999-1003. doi: 10.1093/jac/37.5.999.
8
Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae.克拉霉素治疗龟分枝杆菌引起的皮肤(播散性)感染的临床试验。
Ann Intern Med. 1993 Sep 15;119(6):482-6. doi: 10.7326/0003-4819-119-6-199309150-00006.
9
Antibiotic susceptibility of Mycobacterium marinum.海分枝杆菌的抗生素敏感性
Scand J Infect Dis. 1993;25(6):779-82. doi: 10.3109/00365549309008579.
10
Mycobacterium marinum skin infections. Report of 31 cases and review of the literature.海分支杆菌皮肤感染。31例报告及文献复习
Arch Intern Med. 1994 Jun 27;154(12):1359-64. doi: 10.1001/archinte.154.12.1359.

海分枝杆菌的抗生素敏感性模式

Antibiotic susceptibility pattern of Mycobacterium marinum.

作者信息

Aubry A, Jarlier V, Escolano S, Truffot-Pernot C, Cambau E

机构信息

Laboratoire de Bactériologie-Hygiène et Centre National de Référence pour la Surveillance des Infections à Mycobactéries et de leur Résistance aux Antituberculeux, Faculté de Médecine Pitié-Salpêtrière, Paris, France.

出版信息

Antimicrob Agents Chemother. 2000 Nov;44(11):3133-6. doi: 10.1128/AAC.44.11.3133-3136.2000.

DOI:10.1128/AAC.44.11.3133-3136.2000
PMID:11036036
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC101616/
Abstract

In vitro activities of 17 antibiotics against 53 clinical strains of Mycobacterium marinum, an atypical mycobacterium responsible for cutaneous infections, were determined using the reference agar dilution method. Rifampin and rifabutin were the most active drugs (MICs at which 90% of the isolates tested were inhibited [MIC(90)s], 0.5 and 0.6 microgram/ml, respectively). MICs of minocycline (MIC(90), 4 microgram/ml), doxycycline (MIC(90), 16 microgram/ml), clarithromycin (MIC(90), 4 microgram/ml), sparfloxacin (MIC(90), 2 microgram/ml), moxifloxacin (MIC(90), 1 microgram/ml), imipenem (MIC(90), 8 microgram/ml), sulfamethoxazole (MIC(90), 8 microgram/ml) and amikacin (MIC(90), 4 microgram/ml) were close to the susceptibility breakpoints. MICs of isoniazid, ethambutol, trimethoprim, azithromycin, ciprofloxacin, ofloxacin, and levofloxacin were above the concentrations usually obtained in vivo. For each drug, the MIC(50), geometric mean MIC, and modal MIC were very close, showing that all the strains had a similar susceptibility pattern. Percent agreement (within +/-1 log(2) dilution) between MICs yielded by the Etest method and by the agar dilution method used as reference were 83, 59, 43, and 24% for minocycline, rifampin, clarithromycin, and sparfloxacin, respectively. Reproducibility with the Etest was low, in contrast to that with the agar dilution method. In conclusion, M. marinum is a naturally multidrug-resistant species for which the agar dilution method is more accurate than the Etest for antibiotic susceptibility testing.

摘要

采用参考琼脂稀释法测定了17种抗生素对53株海分枝杆菌临床菌株的体外活性,海分枝杆菌是一种引起皮肤感染的非典型分枝杆菌。利福平和利福布汀是活性最强的药物(90%受试菌株被抑制时的最低抑菌浓度[MIC(90)s]分别为0.5和0.6微克/毫升)。米诺环素(MIC(90),4微克/毫升)、多西环素(MIC(90),16微克/毫升)、克拉霉素(MIC(90),4微克/毫升)、司帕沙星(MIC(90),2微克/毫升)、莫西沙星(MIC(90),1微克/毫升)、亚胺培南(MIC(90),8微克/毫升)、磺胺甲恶唑(MIC(90),8微克/毫升)和阿米卡星(MIC(90),4微克/毫升)的MIC接近药敏折点。异烟肼、乙胺丁醇、甲氧苄啶、阿奇霉素、环丙沙星、氧氟沙星和左氧氟沙星的MIC高于体内通常获得的浓度。对于每种药物,MIC(50)、几何平均MIC和众数MIC非常接近,表明所有菌株具有相似的药敏模式。Etest法与作为参考的琼脂稀释法所得MIC之间的百分比一致性(在±1 log(2)稀释范围内),米诺环素、利福平、克拉霉素和司帕沙星分别为83%、59%、43%和24%。与琼脂稀释法相比,Etest法的重现性较低。总之,海分枝杆菌是一种天然耐多药菌种,对于其抗生素药敏试验,琼脂稀释法比Etest法更准确。